Clinical Trial Update: Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating XP chemotherapy and XP with radiotherapy after surgical resection for gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Xeloda (capecitabine) (capecitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer, Surgery | Phase 3 | Status: COMPLETED